WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016106237) POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/106237    International Application No.:    PCT/US2015/067155
Publication Date: 30.06.2016 International Filing Date: 21.12.2015
IPC:
C07D 471/04 (2006.01), C07D 491/147 (2006.01), A61K 31/4375 (2006.01), A61P 31/18 (2006.01)
Applicants: GILEAD SCIENCES, INC. [US/US]; 333 Lakeside Drive Foster City, CA 94404 (US)
Inventors: BACON, Elizabeth, M.; (US).
CAI, Zhenhong, R.; (US).
COTTELL, Jeromy, J.; (US).
JI, Mingzhe; (US).
JIN, Haolun; (US).
LAZERWITH, Scott, E.; (US).
MORGANELLI, Philip, Anthony; (US).
PYUN, Hyung-jung; (US)
Agent: CAPPS, Kevin; (US)
Priority Data:
62/096,291 23.12.2014 US
Title (EN) POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
(FR) COMPOSÉS CARBAMOYLPYRIDONES POLYCYCLIQUES ET LEUR UTILISATION PHARMACEUTIQUE
Abstract: front page image
(EN)Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (la): (la) including stereoisomers and pharmaceutically acceptable salts thereof, wherein A', R1, R2 and R3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
(FR)La présente invention concerne des composés à utiliser dans le traitement d'une infection à virus de l’immunodéficience humaine (VIH). Lesdits composés correspondent à la formule (Ia). La présente invention concerne également des stéréoisomères et des sels pharmaceutiquement acceptables desdits composés. Dans la formule (Ia), A', R1, R2 et R3 sont tels que définis dans la description. La présente invention concerne en outre des méthodes associées à la préparation et à l’utilisation de ces composés, ainsi que des compositions pharmaceutiques contenant de tels composés.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)